Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG37390

KANK2 Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

The KANK2 Knockout HeLa Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population in the HeLa cervical adenocarcinoma cell line, targeting the KANK2 gene. KANK2 is a scaffold protein that orchestrates integrin-mediated adhesion and actin dynamics by recruiting talin-1 and interacting with vinculin and Rho GTPases at focal adhesions. Loss of KANK2 destabilizes adhesion complexes and impairs cell motility, making these cells ideal for investigating cancer metastasis, cytoskeletal reorganization, and adhesion signaling. Typical applications include wound healing, transwell migration, and focal adhesion staining assays, as well as drug screening for adhesion inhibitors.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    KANK2

    Gene Identifier

    NCBI Gene ID 25959

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

KANK2 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting the KANK2 gene in HeLa cells. Utilizing CRISPR/Cas9-mediated gene disruption, this product provides a heterogeneous pool of cells with stable KANK2 inactivation for loss-of-function studies. The polyclonal format maintains population diversity, offering a versatile model to investigate focal adhesion dynamics and actin cytoskeleton regulation in cervical adenocarcinoma. The knockout cells allow dissection of KANK2 function in a cancer-relevant background.

HeLa is an immortalized cervical adenocarcinoma epithelial cell line derived from Henrietta Lacks, exhibiting HPV18-positive status and epithelial morphology. Widely used in cancer research, HeLa cells display robust integrin-mediated adhesion and migration, making them an optimal host for studying genes involved in cytoskeletal dynamics and cell motility. Their well-established use in metastasis and signaling assays provides a reliable platform for knockout studies.

KANK2 encodes a scaffold protein essential for integrin-mediated adhesion and actin cytoskeleton remodeling. At focal adhesions, KANK2 interacts with talin-1, vinculin, and ??-catenin, and forms complexes with 14-3-3 proteins, PI3K, and ILK. It operates downstream of integrin receptors and mechanical stress, and upstream of Rho GTPases such as RhoA, regulating F-actin assembly via PIP5K1?? and ROCK. KANK2-mediated talin recruitment stabilizes adhesion complexes; knockout disrupts focal adhesion integrity, impairing cell adhesion and motility.

In HeLa cells, KANK2 knockout destabilizes focal adhesions, reducing adhesion and migration??key phenotypes for cancer metastasis research. This model enables dissection of KANK2-dependent pathways that drive tumor cell dissemination. Additionally, KANK2 mutations are linked to focal segmental glomerulosclerosis and nephrotic syndrome, highlighting broader relevance in adhesion-related pathologies. The knockout cells offer a system to study the convergence of mechanical and biochemical signals on the actin cytoskeleton.

These cells are ideal for functional assays such as wound healing, transwell migration, and adhesion assays to quantify motility and adhesive strength. Immunofluorescence staining of focal adhesion components (e.g., vinculin, talin) visualizes complex integrity, while western blotting assesses talin, vimentin, and Rho GTPase activity. They also support drug screening for adhesion inhibitors. For additional information, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)